| Value | ₹69.00 Cr |
|---|
NSE filing, NSE: KRISHNADEF. Summary written from the filing by ALFA Finder's alert engine.
Krishna Defence and Allied Industries Ltd: key numbers
- Share price
- ₹1,150.30
- Market cap
- ₹1,719 Cr
- Revenue (annual)
- ₹244.8 Cr
- Net profit (annual)
- ₹41.32 Cr
- P/E (TTM)
- 39.7×Sector 52.8×
- Promoter holding
- 55.22%-4.68% QoQ
- FII holding
- 0.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Krishna Defence and Allied Industries Ltd
All →Krishna Defence and Allied Industries Dividend
Krishna Defence board declared an interim dividend of Rs 0.75 per equity share on October 29, 2026. The record date for the dividend is November 5, 2026.
Krishna Defence and Allied Industries Q2 FY27 Results: Net Profit ₹1,532 Cr, Up 71.8% YoY
Krishna Defence and Allied Industries Ltd reported revenue from operations of ₹7,529 Cr (+55.7% YoY) and net profit of ₹1,532 Cr (+71.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,532 Cr · +71.8% YoY
Krishna Defence and Allied Industries Board Meeting Date
Krishna Defence will hold a board meeting on 29 October 2026 to consider September 2026 quarter results and interim dividend. Trading window closes until 31 October 2026.
Krishna Defence and Allied Industries Price Movement Clarification
Krishna Defence clarifies no undisclosed information exists behind its recent price spike. The trading window remains closed since October 1, and movements are attributed to market conditions.
Krishna Defence and Allied Industries Credit Rating
CRISIL reaffirmed Krishna Defence's credit ratings for its bank facilities. Long-term rating is BBB with Positive outlook; short-term is A3+.
Krishna Defence and Allied Industries Announces New Order Win
Krishna Defence and Allied Industries Limited won the DRISHTI Challenge by Yantra India Limited. The company will develop and manufacture specialized defence components for the Armed Forces.
Other credit rating announcements
All →Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.
Shiva Cement Credit Rating
Crisil reaffirmed long-term credit ratings of A+/Stable and AA-(CE)/Stable for Shiva Cement's bank loan facilities. The ratings remain unchanged with stable outlook across all six facilities.